Report Highlights
- Global revenues from chromatography reagents totaled nearly $4.3 billion in 2011 and $5.2 billion in 2012. Total revenues should reach $11.9 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 18%.
- Ion exchange chromatography is the only other segment expected to reach $1 billion in value over the next five years. This segment should be worth $700 million in 2012 and $1.1 billion in 2017, a CAGR of 9.8%.
- The global sales from solvents used in ion-exchange chromatography are expected to reach $245.2 million in 2012 and $372.8 million in 2017, a CAGR of 8.7%.
INTRODUCTION
STUDY OBJECTIVES
The purpose of this study, conducted by BCC, is to offer a synopsis of the current characteristics of the global market for chromatography reagents in order to forecast its future. The key intent is to provide an extensive analysis of the current market and the future trends for the chromatography reagents market. The report offers analysis on the market size, market leaders, and factors affecting the market of chromatography reagents from the perspective of its end users, which includes the pharma and biotech, food and beverages, environmental agencies and other sectors.
This report investigates current and future strategies within the chromatography techniques and reagents market. The report takes a close look at the market’s inventiveness, its setbacks and future needs. The comparisons, usage and the advantages and disadvantages of different types of chromatography products and reagents are also covered in this report.
A comprehensive analysis of chromatography reagents sales is given, broken down by regions—North America, Europe and emerging markets. Sales figures are forecast for the five-year period from 2012 through 2017.
REASONS FOR DOING THIS STUDY
Chromatography techniques and reagents are being used extensively in pharmaceutical and biotechnology industries in the development of pure drug compounds. The primary usage of chromatography techniques is for quality assurance of drug products wherein chromatography separation techniques can, in some cases, assure up to 99.9% purity level and can reveal the impurities to 0.1% or even smaller. These separations or analysis techniques use chromatography reagents for the measurement of the drug purity, which has led to the growing market of the reagents. The study thus focuses on the usage of these reagents in various industries across the global markets.
Most of the techniques of chromatography and their reagents are discussed in this report. The fast-changing scenarios and developmental landscape of various technologies in the market justify focusing on this segment. Along with the end users—pharmaceutical and biotech, food and beverage, environmental agencies and other industries—merger and acquisition and collaborations of companies are also covered in this report. This study also discusses the strengths and weaknesses of each reagent type/technology in light of new technologies, growing competition and changing customer needs.
CONTRIBUTIONS OF THE STUDY AND ITS AUDIENCE
This study contributes to knowledge and understanding of market growth and setbacks for chromatography reagents from the manufacturer and end user perspectives. Pharmaceutical, biochemical, chemical, petrochemical, food and beverage industries, clinics, forensics and environmental agencies will find this study to be of interest.
SCOPE OF THE STUDY
The scope of this study comprises the markets of reagents of chromatography along with various chromatography techniques. BCC analyzes each market; the different types of chromatographic techniques and reagents; the regulatory aspects; the end users of the chromatographic reagents and market projections, its market leaders and market share. The study also offers details of technological refinements including the latest trends and developments.
METHODOLOGY
Both primary and secondary research methodologies were used in preparing this study. BCC carried out a comprehensive literature search that included technical newsletters, journals, technical blogs and research papers as well as many other sources. The data were collected through interviews and correspondence with various pharmaceutical, biotechnical, food and beverage and environment experts. Projections were based on estimates such as the current number of end users, potential end users, likely unit prices, rates of consumption and market trends.
INFORMATION SOURCES
BCC surveyed various companies within the industry to obtain data for this study. They were reputed manufacturers and end users of chromatographic reagents in pharmaceutical, chemical, biotechnology, food & beverages and other relevant industries. BCC spoke with officials within the industry, consulted newsletters, company literature, product literature, technical articles, journals, indexes and abstracts. Exhaustive investigations of databases by key terminology were done. In addition, data were compiled from current financial, trade and governmental sources.
BCC ON-LINE SERVICES
BCC Research offers an online information retrieval service. Its home page, located at www.bccresearch.com, enables readers to:
- Examine the complete BCC Research catalog of market research reports and place direct orders.
- Subscribe to any of BCC Research’s many industry newsletters.
- Read announcements of recently published reports and newly launched newsletters.
- Register for its well-known conferences.
- Request additional information on any BCC research product.
- Take advantage of special offers.
DISCLAIMER
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal or accounting advice, nor should it serve as a corporate policy guide, laboratory manual or an endorsement of any product, as much of the information is of a speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or from its use.
Analyst Credentials
Shalini Shahani Dewan focuses on pharmaceuticals and biotechnology and has been a BCC Research contributor since 2002 as both an analyst and project manager. She has explored a wide range of topics and companies, including working for Johnson & Johnson doing market surveillance. She has an undergraduate degree in pharmacy and master's degree in medicinal chemistry. She resides in the Bay Area.
Related Reports
Global Markets for Enzyme Inhibitors
The global market for enzyme inhibitors was valued at $104.4 billion in 2010 and reached nearly $104.6 billion in 2011. This market is expected to rise at a compound annual growth rate (CAGR) of 4% and reach nearly $127.4 billion by 2016.
Global Markets for Chiral Technology
The global chiral technology market was worth nearly $5.3 billion in 2011. This market is expected to increase at a CAGR of 6.5% from 2011 to 2016 and will approach $7.2 billion by the end of the forecast period.
Antibody Drugs: Technologies and Global Markets
The global market for therapeutic monoclonal antibodies (mAbs) was estimated at $44.6 billion in 2011. With the rollout of at least eight new therapeutic mAb products and expanded indications for existing products expected during the forecast period, the global mAb market is expected to rise at a compound annual growth rate (CAGR) of 5.3% to nearly $58 billion in 2016.
Separation Systems for Commercial Biotechnology
The global market for commercial biotechnology separation systems reached $12.1 billion in 2010, $14.6 billion in 2011, and it will further grow to $26.7 billion at an estimated compound annual growth rate (CAGR) of 12.8% by 2016.
Recent Reports
Major Reverse Osmosis System Components for Water Treatment: The Global Market
The global market for RO system components is expected to grow from $18.8 billion in 2024 and is projected to reach $32.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.2% during the forecast period of 2024 to 2029.
Ultrafiltration Membranes: Technologies and Global Markets
The global market for ultrafiltration membranes was valued at $4.9 billion in 2023. The market is expected to grow from $5.2 billion in 2024 to $8.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 9.4% from 2024 to 2029.
Pharmaceutical Filtration: Global Markets
The global market for pharmaceutical filtration was valued at $10.4 billion in 2023. The market is estimated to grow from $11.4 billion in 2024 to $18.1 billion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 to 2029.
Water Filtration: Global Markets
The global market for water filtration is expected to grow from $10.5 billion in 2024 and is projected to reach $19.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.5% during the forecast period of 2024 to 2029.
Seawater and Brackish Water Desalination
The global market for seawater and brackish water desalination is estimated to increase from $17.4 billion in 2023 to reach $25.7 billion by 2028, at a compound annual growth rate (CAGR) of 8.1% from 2023 through 2028.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More